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Little is known regarding the changing seasonality of infections with the tick-borne encepha-
litis virus (TBEV) and the incidence of the resulting disease over the last two decades. Sea-
sonal patterns have to our knowledge not previously been systematically investigated and
are poorly understood. We investigate emerging seasonal changes in clinical aspects like
potentially increasing hospitalization during the year, variations in clinical symptoms and dis-
ease severity during the season and seasonal dynamics of fatal outcomes.
Material and methods
TBEV infection became a notifiable disease in Germany in 2001. We used the national
reporting dataset spanning from 2001–2018, provided by the Robert Koch-Institute (RKI).
There were general epidemiological variables available, including “symptom onset”, “age”
and “sex”. Furthermore, several variables documented disease severity. These included
“CNS symptoms”, “myelitis”, “fatal outcome” and “hospitalization”. Potential factors influenc-
ing the occurrence of CNS symptoms, myelitis, hospitalizations and fatal outcome were ana-
lyzed using logistic regression models. Linear trends, including the “time point in year” at
which TBEV infection related symptoms were detected, were tested using calendar year as
a continuous covariate. In addition, seasonal trends and age and sex specific differences
were exploratively tested for non-linear effects using restricted cubic splines with knot loca-
tions based on Harrell’s recommended percentiles. Finally, the dynamic relationship
between in-seasonal trends year of detection, sex and age was tested using interaction
terms.
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Kreusch TM, Dobler G (2019) Tick-borne
encephalitis virus infections in Germany.
Seasonality and in-year patterns. A retrospective
analysis from 2001-2018. PLoS ONE 14(10):
e0224044. https://doi.org/10.1371/journal.
pone.0224044
Editor: Abdallah M. Samy, Faculty of Science, Ain
Shams University (ASU), EGYPT
Received: June 22, 2019
Accepted: October 3, 2019
Published: October 31, 2019
Copyright: © 2019 Borde et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The dataset is
available on reasonable request by the authors/RKI.
We opted for this way of datasharing, because
there are concerns regarding sensitive patient
information / or potentially patient identifying
information - especially in the context of a fatal
outcome (small sample size). The dataset is a
national surveillance dataset, restrictions are stated
by the institutional body Robert Koch-Institute
(RKI), which is a federal public health authority. In
detail the dataset is available at: 1. Teresa M.
Results
6,073 TBEV infection cases from 2001–2018 were included in our analysis. We find that
from 2001–2018 TBEV infections are reported 0.69 days earlier each year (p<0.001). There
was no detectable seasonal variation regarding the occurrence of fatal outcome, CNS and
myelitis. However, there was a significant changing trend regarding hospitalizations over
the course of the year: The risk for hospitalization increases until August, decreases again
from October on.
Conclusion
We present epidemiological evidence that the TBE season in Germany has shifted to start
earlier over the last years, beginning approximately 12 days earlier in 2018 than it did in
2001. There are seasonal patterns regarding a higher risk of hospitalization during August.
Introduction
Tickborne encephalitis (TBE) is endemic in Central Europe, in Eastern Europe, in parts of
Northern Europe and especially in the Baltics. TBE is the most important arboviral disease in
Europe and Northern Asia, with 10.000–15.000 cases each year [1]. TBE is caused by the tick-
borne encephalitis virus (TBEV), which is a member of the Flaviviridae family [2,3]. TBEV
shares many genetic features with other mosquito-borne and tickborne flaviviruses, such as
Dengue virus (DENV), Zika virus (ZIKV), Yellowfever virus (YFV) and Powassan virus
(POWV). This virus’s first scientific description dates back to 1938, as part of a dramatic effort
to combat an epidemic of encephalitis among troops in the far east of the USSR. A vaccine was
quickly developed and put into use in 1939 [4].
Five genetic subtypes of TBEV are currently acknowledged to exist, the Baikalian, the Far
Eastern, the Himalayan, the Siberian, and the Western subtypes, of which the Baikalian and
Himalayan are relatively recent discoveries [5]. Vaccination is the main defense against the
virus, since as of now no specific antiviral treatment exists. Once it has occurred, TBEV infec-
tion can lead to severe and sometimes lasting ill health effects and even death, with a mortality
rate of 1% reported for the Western type that is prevalent in Germany. This of course is linked
to a considerable use of medical resources [1,6–8]. The available vaccines, Encepur1 by GSK
and FSME Immun1 by Pfizer, fortunately offer very good protection and are safe, with more
than 98% of patients completing the basic vaccination schedule exhibiting seroconversion [9].
However, for a variety of reasons many of those at risk in Europe are not vaccinated, with vac-
cination rates often far below the>85% seen in Austria, the country with the highest rate. In
Germany, only 27% of the population have ever received even a single TBEV shot [10].
Several aspects of TBE epidemiology, TBE disease and vaccination remain a matter of
debate. Descriptive results using the national surveillance dataset were published before by
Hellenbrand et al. [11], however long-term trends have been studied with a particular focus on
the geographic spread and related dynamics of human TBEV infections [11,12], in order to
detect high-risk regions. We want to answer questions regarding the changing seasonality of
TBE incidence over the last two decades. Seasonal patterns have to our knowledge not been
systematically investigated previously and are poorly understood. We investigate emerging
seasonal changes in clinical aspects like potentially increasing hospitalization during the year,
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TBEV infections became a notifiable disease in Germany in 2001. National (by the German
Robert Koch Institute, RKI) and European case definition (by the European Centre of Disease
Prevention and Control, ECDC) criteria have been issued. The dataset and definitions of clini-
cal variables have been published before by Hellenbrand et al. [11].
In detail [11] these variables are characterized as following: “either non-specific symptoms
or central nervous system (CNS) symptoms indicating CNS infection (meningitis, encephalitis
or myelitis separately or in combination) and laboratory confirmation of either simultaneously
elevated IgM and IgG TBEV-specific antibodies in serum or cerebrospinal fluid (CSF), an
increase in TBEV-specific IgG antibodies in two serum samples or the detection of intrathecal
antibody synthesis [13]. Until 2004, the detection of increased IgM TBEV-specific antibodies
was considered sufficient for laboratory diagnosis. General epidemiological variables docu-
mented included “symptom onset”, “age” and “sex”. Furthermore, several variables docu-
mented disease severity. These included “CNS symptoms”, “myelitis”, “fatal outcome” and
“hospitalization”. In detail, “CNS symptoms” defines the presence of unspecific symptoms or
specific CNS symptoms. The item “myelitis” has been reported separately since 2001. There is
detailed information included regarding vaccination history of the patients.[11]”
Statistical methods
Potential factors influencing the occurrence of CNS symptoms, myelitis, hospitalizations and
fatal outcome were analyzed using logistic regression models. Linear trends, including the
“time point in year” at which TBEV infection related symptoms were detected, were tested
using a linear regression analysis with calendar year as a the single continuous explanatory var-
iable. For missing values regarding onset of symptoms median imputation using the reporting
date was applied on an annual basis. This means that the annual mean difference between
onset of symptoms and reporting date was imputed. The endpoints myelitis, CNS symptoms,
hospitalization and fatal outcome were analyzed for seasonality using logistic regression mod-
els. Therefore, the “time point in year” at which TBEV infection related symptoms were
detected was included as a continuous but non-linear covariate. The non-linearity was mod-
elled using restricted cubic splines with knot locations based on Harrell’s recommended per-
centiles [14]. Based on the results of these logistic regression models, predicted probabilities
were calculated and explored graphically. Finally, the dynamic relationship between in-sea-
sonal trends, year of detection, sex and age was tested using interaction terms. In case that the
p-value of the interaction term indicated different in-seasonal trends for specific subgroups,
these differences were explored graphically. All analyses were conducted using STATA 15.1
(College Station, Texas, USA) and Microsoft Excel1 software.
Results
General epidemiology
6,073 TBEV infection cases from 2001–2018 were included in our analysis, regardless of the
vaccination status. Sufficient information on the vaccination status was available for 5,777
cases. 5,298 presented with a native TBEV infection and 479 with an infection despite having
been vaccinated at least once. Descriptive results using this set of data were published before
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by Hellenbrand et al. [11]. For a general study population overview see Table 1, which has
been published/submitted in parts before with a different research background and question
than this manuscript.
Seasonality, the long-term perspective, 2001–2018
June and July had the highest frequency of TBEV infections (S1 Fig). Analyzing the develop-
ment over the years we found that TBEV infections are reported 0.69 days earlier each year
(p<0.001). In addition to the date at which TBE cases were reported (notification date), the
date of disease/symptom onset was available for 88% (N = 5,323) of the TBE cases. On average,
disease onset was 19.07 days [95%CI 18.50–19.64] before the cases were reported. Further-
more, the onset of symptoms showed a comparable trend (0.67 days earlier each year,
p<0.001) as the reporting date. The TBE season in Germany thus started approximately 12
days earlier in 2018 than it did in 2001.
Seasonal trends and patterns, 2001–2018
We further analyzed whether there was a significant in-year seasonality in the variables fatal
outcome, hospitalization, CNS and myelitis. There was no detectable seasonal variation
regarding the variable myelitis, CNS and fatal outcome (Fig 1). However, there was a signifi-
cant trend in hospitalizations over the course of the year (Fig 1). The risk for hospitalization
increases until August, and then decreases again from October on.
Subgroup-specific changes of in-season trends and patterns
Sex-specific differences in seasonal trends were observed for the endpoint fatal outcome only
(p-value of interaction term 0.088). As shown in Fig 1 female patients, who died, had an onset
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of symptoms 38.98 days later (p = 0.007) than their male counterparts. Age-specific differences
in seasonal trends were not observed (all p-value of interaction terms >0.1).
As shown in Fig 2, the seasonal trend of CNS and myelitis occurrence changes substantially
over the years (p-value of interaction terms: 0.007 and 0.001, respectively). For the early years
(2001–2009), an autumn decrease of CNS and myelitis was detected. For the later years (2010–
2018), however, there is a steep increase in CNS and myelitis occurrence in autumn. No such
changes in trend were observed for the other variables.
Discussion
The analyzed dataset provides evidence of a shift of the TBE season in Germany towards an
earlier beginning, by approximately 12 days over the last eighteen years. Such a shift was pro-
posed before on the basis of large dataset from the Czech Republic 1970–2008, however com-
pared and analyzed on a coarser time scale, in 10 year blocks [15]. The link with climate
change is obvious, however interactions are complex and poorly understood. TBE infections
and reported TBE cases are mainly influenced by two variables, first human exposure or out-
door activity and second by tick activity itself. Both factors are linked to a plethora of inter-
plays, which include wildlife cycles, socioeconomic factors, meteorological parameters like
temperature, precipitation rate and air humidity [16,17]. Overall, the number of TBE cases
seems to be more dependent on host activity than on tick activity itself [18,19]. It is speculated
that climate change increases host outdoor activity, i.e. earlier outdoor and recreational activ-
ity, more than it affects vector cycles. It might be of future research interest to identify factors
which predict or affect human activity–e.g. perceived temperature or beginning of the vegeta-
tion period. The earlier beginning of the TBE season should prompt health care providers and
health care authorities to anticipate emerging TBE cases as early as March or early April.
The seasonal trend of an increasing hospitalization rate, peaking in August/September, is a
new finding. A seasonal dynamic of the item “fatal outcome” shows in the summer months,
but without reaching statistical significance. Possible explanations for the hospitalization phe-
nomenon include virological and hospital-economic factors. Virological considerations
include the seasonal occurrence of different pathogenic TBEV quasi-species, and varying TBE
viral load in ticks over the season, which might cause different clinical forms. However, these
hypotheses are far from being proven. In particular there is no correlation to other clinical var-
iables like CNS and myelitis. There might also be a hospital-economic effect, resulting in a
lower threshold for hospital admittance during the summer months. This period is typically
associated with a decreased number of inpatients due to seasonal holidays and low season for
respiratory tract infections like influenza. For the early years (2001–2009), an autumn decrease
of CNS and myelitis was detected. However, in the later years (2010–2018), there was even a
strong increase of CNS and myelitis occurrence in autumn. These findings are based on large
numbers (n = 2800 for CNS, n = 188 for myelitis), but difficult to explain. From a virological
point of view one might again speculate about changing seasonal pathogenicities of different
TBEV quasispecies over the years, but, as mentioned above, these hypotheses are far from
Fig 1. Seasonal analysis—It is shown, that there was no detectable seasonal variation regarding the variables
myelitis, CNS and fatal outcome (Fig 1). However, there is a significant seasonal trend regarding hospitalization,
which increases until August (d) It is shown that there was no detectable seasonal variation regarding the variable fatal
outcome (c). In (e), female patients who died, had a later onset of symptoms than their male counterparts. Predicted
probabilities and corresponding 95% confidence intervals (shaded area) based on the results of logistic regression
models with the time point in year at which TBEV infection related symptoms were detected included as a continuous
but non-linear covariate. Non-linearity was modelled using restricted cubic splines with knot locations based on
Harrell’s recommended percentiles [14].
https://doi.org/10.1371/journal.pone.0224044.g001
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being proven. Another approach to explain these findings would be the increase in the number
of magnetic imaging (MRI) procedures over the last ten years—especially in MRI procedures
of the CNS. This might lead to a higher number of radiological myelitis diagnoses, which are
not always in-line with the presence of clinical symptoms for myelitis.
There is a seasonal difference regarding the variable fatal outcome between male and female
patients. Female patients, who died, had an onset of symptoms later during the year than their
male counterparts. The results must be interpreted with caution in the context of the overall
small number of patients with a fatal outcome (n = 25).
Our study has several limitations. In view of the used dataset, there is no scoring of disease
severity as was proposed in previous literature [20], nor a source data verification of the
reported cases was done. Clinical information is exclusively derived from formalized inter-
views, which were conducted by the public health authorities. In detail, public health physi-
cians and public health officers contact the patient, hospital care providers and/or primary
care providers to gather data. This might result in a unknown number of incorrect reported
and documented variables. Furthermore, the time of the interview is not defined, therefore
some cases are contacted very early in the course of the disease and other delayed.
In conclusion, we present epidemiological evidence that the TBE seasons starts earlier over
the last years. There are in-seasonal patterns regarding a higher risk of hospitalization during
August.
Supporting information
S1 Fig. Overall cumulative frequency of reported TBEV cases (diseases onset) over the year
spanning the study period 2001–2018. Each month is subdivided into four bars. Peak fre-
quency is detected in the months June and July.
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3. Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L, Karganova G, et al. Tick-borne encephalitis in
Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res.
2019; 164: 23–51. https://doi.org/10.1016/j.antiviral.2019.01.014 PMID: 30710567
4. Zlobin VI, Pogodina V V., Kahl O. A brief history of the discovery of tick-borne encephalitis virus in the
late 1930s (based on reminiscences of members of the expeditions, their colleagues, and relatives).
Ticks Tick Borne Dis. 2017; 8: 813–820. https://doi.org/10.1016/j.ttbdis.2017.05.001 PMID: 28526419
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